[Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer].

Abstract

A 64-year-old man was admitted to our hospital for 6th-line chemotherapy. Chest X-ray film and computed tomographic (CT) scan showed right-sided pleural thickening with multiple lung tumors. Repeated treatment with carboplatin (AUC 6), paclitaxel (200 mg/m(2)) and bevacizumab (150 mg/kg) on day 1 every 21 days was effective for this patient. Chemotherapy with bevacizumab may be effective for patients with multi-recurrent adenocarcinoma.

• Authors: Yoshihisa Ishiura, Hiroki Yamamoto, Yasushi Terasaki, Youichi Ishida, Masayoshi Tohge, Masataka Segawa, Yoshinori Kusajima, Katsuhiko Saitoh, Mika Ishikawa, Norikazu Hirokami, Kazuo Kasahara, Masaki Fujimura
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 38 Issue 13 Pg. 2631-3 (Dec 2011) ISSN: 0385-0684 [Print] Japan
• PMID: 22189231 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Antibodies, Monoclonal, Humanized
• Bevacizumab
• Carboplatin

Topics

• Antibodies, Monoclonal, Humanized (administration & dosage, therapeutic use)
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Bevacizumab
• Carboplatin (therapeutic use)
• Carcinoma, Non-Small-Cell Lung (drug therapy, pathology)
• Humans
• Lung Neoplasms (drug therapy, pathology)
• Male
• Middle Aged
• Neoplasm Staging
• Recurrence
• Salvage Therapy
• Tomography, X-Ray Computed